Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B5W9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.522 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.522 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.785 |
DEG_SPOP_SBC_1 | 77 | 81 | PF00917 | 0.714 |
DEG_SPOP_SBC_1 | 83 | 87 | PF00917 | 0.735 |
DOC_CYCLIN_yCln2_LP_2 | 47 | 53 | PF00134 | 0.591 |
DOC_PP2B_LxvP_1 | 111 | 114 | PF13499 | 0.651 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.720 |
DOC_USP7_UBL2_3 | 159 | 163 | PF12436 | 0.689 |
DOC_USP7_UBL2_3 | 6 | 10 | PF12436 | 0.701 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.698 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.757 |
LIG_14-3-3_CanoR_1 | 146 | 152 | PF00244 | 0.602 |
LIG_LIR_Gen_1 | 107 | 115 | PF02991 | 0.652 |
LIG_LIR_Nem_3 | 107 | 113 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.579 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.645 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.505 |
LIG_SH3_3 | 86 | 92 | PF00018 | 0.777 |
LIG_SUMO_SIM_anti_2 | 135 | 141 | PF11976 | 0.402 |
MOD_CDK_SPxK_1 | 4 | 10 | PF00069 | 0.662 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.677 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.758 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.729 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.683 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.614 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.658 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.635 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.703 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.552 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.781 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.601 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.632 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.640 |
MOD_PKA_2 | 145 | 151 | PF00069 | 0.713 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.558 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.571 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.730 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.680 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.700 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.593 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.753 |
MOD_SUMO_rev_2 | 27 | 32 | PF00179 | 0.687 |
MOD_SUMO_rev_2 | 97 | 102 | PF00179 | 0.752 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.642 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3P8 | Leptomonas seymouri | 62% | 93% |
A0A1X0NIU2 | Trypanosomatidae | 35% | 100% |
A0A3R7KNC4 | Trypanosoma rangeli | 35% | 96% |
A0A3S7X8W7 | Leishmania donovani | 91% | 100% |
A4HMC0 | Leishmania braziliensis | 81% | 100% |
A4IAY6 | Leishmania infantum | 90% | 100% |
C9ZNI3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AER4 | Leishmania major | 92% | 100% |
V5D1X1 | Trypanosoma cruzi | 37% | 99% |